Tilray researches, cultivates, processes and globally distributes medical cannabis. Tilray supplies high-quality cannabis products to tens of thousands of patients in ten countries on five continents.
E Squared Invested in Series A preferred shares in January 2018 at a $600 million valuation. Tilray went public on NASDAQ on 7/18/2018 at a $1.63B valuation.
E Squared invested in Juul Series D preferred shares in January 2017 at a $207 million valuation. Most recent capital raised at a $16B valuation.